CZ20011886A3 - Etanolát azitromycinu, postup přípravy a jeho farmaceutické preparáty - Google Patents

Etanolát azitromycinu, postup přípravy a jeho farmaceutické preparáty Download PDF

Info

Publication number
CZ20011886A3
CZ20011886A3 CZ20011886A CZ20011886A CZ20011886A3 CZ 20011886 A3 CZ20011886 A3 CZ 20011886A3 CZ 20011886 A CZ20011886 A CZ 20011886A CZ 20011886 A CZ20011886 A CZ 20011886A CZ 20011886 A3 CZ20011886 A3 CZ 20011886A3
Authority
CZ
Czechia
Prior art keywords
azithromycin
ethanolate
ethanol
suspension
water
Prior art date
Application number
CZ20011886A
Other languages
Czech (cs)
English (en)
Inventor
Claude Singer
Judith Aronhime
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22332273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CZ20011886(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of CZ20011886A3 publication Critical patent/CZ20011886A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CZ20011886A 1998-11-30 1999-11-30 Etanolát azitromycinu, postup přípravy a jeho farmaceutické preparáty CZ20011886A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11029898P 1998-11-30 1998-11-30

Publications (1)

Publication Number Publication Date
CZ20011886A3 true CZ20011886A3 (cs) 2001-10-17

Family

ID=22332273

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011886A CZ20011886A3 (cs) 1998-11-30 1999-11-30 Etanolát azitromycinu, postup přípravy a jeho farmaceutické preparáty

Country Status (26)

Country Link
US (1) US6365574B2 (https=)
EP (2) EP1484062A1 (https=)
JP (1) JP2002531409A (https=)
KR (1) KR100603226B1 (https=)
CN (2) CN100339384C (https=)
AP (1) AP1709A (https=)
AT (1) ATE279200T1 (https=)
AU (1) AU768219B2 (https=)
BG (1) BG105547A (https=)
CA (1) CA2352562A1 (https=)
CZ (1) CZ20011886A3 (https=)
DE (1) DE69921192T2 (https=)
DK (1) DK1152765T3 (https=)
ES (1) ES2229804T3 (https=)
HK (1) HK1043725B (https=)
HU (1) HUP0104241A3 (https=)
IL (1) IL143376A0 (https=)
LV (1) LV12735B (https=)
NZ (1) NZ512496A (https=)
PL (1) PL197894B1 (https=)
PT (1) PT1152765E (https=)
RO (1) RO121408B1 (https=)
RU (1) RU2240124C2 (https=)
SI (1) SI20639A (https=)
WO (1) WO2000032203A1 (https=)
ZA (1) ZA200104312B (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
SI20639A (sl) * 1998-11-30 2002-02-28 Teva Pharmaceutical Industries Ltd. Etanolat azitromicina, postopek za njegovo pripravo in njegovi farmacevtski sestavki
CN100341886C (zh) * 2000-11-27 2007-10-10 桑多斯股份公司 大环内酯类化合物的溶剂化物
HRP20030430B1 (hr) * 2000-11-27 2011-11-30 Biochemie S.A. Makrolidni solvati
KR100431431B1 (ko) * 2001-04-25 2004-05-14 한미약품 주식회사 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
SI1390377T1 (sl) * 2001-05-22 2006-06-30 Pfizer Prod Inc Nova kristalna oblika azitromicina
ES2258142T3 (es) * 2001-05-22 2006-08-16 Pfizer Products Inc. Nueva forma cristalina.
US6861413B2 (en) * 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
US20080149521A9 (en) * 2001-10-18 2008-06-26 Michael Pesachovich Methods of stabilizing azithromycin
ES2324527T3 (es) * 2001-10-18 2009-08-10 Teva Pharmaceutical Industries Ltd. Composiciones de azitromicina estabilizadas.
EP1541134A3 (en) * 2001-10-18 2007-06-06 Teva Pharmaceutical Industries Limited Stabilized azithromycin compositions
NZ532063A (en) * 2001-12-21 2006-03-31 Pfizer Prod Inc Methods for wet granulating azithromycin
PL371259A1 (pl) * 2001-12-21 2005-06-13 Pfizer Products Inc. Bezpośrednio sprasowywalne preparaty azytromycyny
RU2283092C2 (ru) * 2002-02-01 2006-09-10 Пфайзер Продактс Инк. Сухие гранулированные композиции азитромицина
HRP20020614A2 (en) * 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
US20050101547A1 (en) * 2003-11-06 2005-05-12 Sadatrezaei Mohsen Stabilized azithromycin composition
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
ES2600577T3 (es) * 2003-12-04 2017-02-09 Bend Research, Inc. Procedimiento de pulverización-solidificación que usa un extrusor para preparar composiciones en multipartículas de fármacos cristalinos
MXPA06005913A (es) * 2003-12-04 2006-06-27 Pfizer Prod Inc Formas de dosificacion de multiparticulas de azitromicina por procedimientos basados en liquidos.
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
KR100844628B1 (ko) * 2003-12-04 2008-07-07 화이자 프로덕츠 인크. 제약상 다입자의 제조 방법
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
CA2591744A1 (en) * 2004-12-21 2006-06-29 Pfizer Products Inc. Stable non-dihydrate azithromycin oral suspensions
US20060198895A1 (en) * 2005-03-07 2006-09-07 Kotliar Eleonora M Azithromycin powder for oral suspension compositions
US20090318375A1 (en) * 2005-06-08 2009-12-24 Hanmi Pharm Co., Ltd Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
US20120058936A1 (en) 2009-03-13 2012-03-08 Assistance Publique - Hopitaux De Paris Compositions and methods for elimination of gram negative bacteria
EP3366326A1 (en) * 2009-04-17 2018-08-29 Micell Technologies, Inc. Stents having controlled elution
WO2013088274A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
CN103983730B (zh) * 2014-06-11 2015-09-30 北京市药品检验所 阿奇霉素或其制剂中的杂质检查方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
WO1989000576A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. Azithromycin dihydrate
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
CN1093370A (zh) * 1993-12-10 1994-10-12 北京市集才药物研究所 一种新的阿齐红霉素结晶及其制备方法
CN1161971A (zh) * 1997-01-03 1997-10-15 石家庄制药集团有限公司 一种阿齐霉素结晶及其制备方法
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
SI20639A (sl) * 1998-11-30 2002-02-28 Teva Pharmaceutical Industries Ltd. Etanolat azitromicina, postopek za njegovo pripravo in njegovi farmacevtski sestavki
KR100491183B1 (ko) * 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
ES2258142T3 (es) * 2001-05-22 2006-08-16 Pfizer Products Inc. Nueva forma cristalina.

Also Published As

Publication number Publication date
US20020007049A1 (en) 2002-01-17
CN100339384C (zh) 2007-09-26
AU768219B2 (en) 2003-12-04
CN1737008A (zh) 2006-02-22
ES2229804T3 (es) 2005-04-16
WO2000032203A1 (en) 2000-06-08
EP1484062A1 (en) 2004-12-08
DE69921192D1 (de) 2004-11-18
RO121408B1 (ro) 2007-05-30
JP2002531409A (ja) 2002-09-24
ZA200104312B (en) 2001-11-28
HK1043725B (en) 2005-05-06
ATE279200T1 (de) 2004-10-15
CN1334735A (zh) 2002-02-06
BG105547A (en) 2001-12-31
IL143376A0 (en) 2002-04-21
HUP0104241A3 (en) 2003-12-29
HK1043725A1 (en) 2002-09-27
NZ512496A (en) 2003-02-28
PL347971A1 (en) 2002-05-06
EP1152765A1 (en) 2001-11-14
DK1152765T3 (da) 2005-01-31
KR20010099806A (ko) 2001-11-09
CA2352562A1 (en) 2000-06-08
CN1273142C (zh) 2006-09-06
KR100603226B1 (ko) 2006-08-28
AU3106500A (en) 2000-06-19
PL197894B1 (pl) 2008-05-30
AP1709A (en) 2007-02-27
US6365574B2 (en) 2002-04-02
LV12735A (en) 2001-10-20
RU2240124C2 (ru) 2004-11-20
HUP0104241A2 (hu) 2002-03-28
DE69921192T2 (de) 2006-02-16
EP1152765A4 (en) 2002-07-17
EP1152765B1 (en) 2004-10-13
LV12735B (en) 2002-03-20
AP2001002183A0 (en) 2001-06-30
SI20639A (sl) 2002-02-28
PT1152765E (pt) 2004-12-31

Similar Documents

Publication Publication Date Title
CZ20011886A3 (cs) Etanolát azitromycinu, postup přípravy a jeho farmaceutické preparáty
WO2000032203A9 (en) Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
EP1254146B1 (en) Processes for preparing clarithromycin polymorphs and novel polymorph iv
JP3140703B2 (ja) 新規なエリスロマイシン、それらの製造法及び薬剤としての用途
DK2125850T3 (en) MACROCYCLIC POLYMORPHS, COMPOSITIONS INCLUDING SUCH POLYMORPHS, PROCEDURES FOR PREPARING AND USING THEREOF
SK403591A3 (en) 2-ranitidine hydrochloride form, method of its preparation and pharmaceutical product with its contents
CA2393047A1 (en) 6-o-methylerythromycin a crystal form iii
MXPA04009009A (es) Pseudopolimorfos isoestructurales de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a.
EP1189913B1 (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
KR102617156B1 (ko) 미노사이클린 염기의 새로운 결정다형 형태 및 이의 제조방법
JPH0687881A (ja) ロキタマイシン・一水和物結晶、及びその製造法
HK1118294A (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
JP2003534231A (ja) 新規の６−デオキシエリスロマイシン誘導体、それらの製造方法及びそれらの薬剤としての使用